New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 23, 2014
08:10 EDTNSPHNanosphere signs molecular diagnostic supply agreement with HealthTrust
Nanosphere announced that it has been selected by HealthTrust as a provider of multi-target molecular diagnostic tests for the nearly 1,400 acute care facilities that are part of the HealthTrust membership. Under this agreement, HealthTrust will offer its members access to purchase Nanosphere's portfolio of Verigene multiplex molecular diagnostic infectious disease tests, including those designed to rapidly and accurately detect infections of the bloodstream, respiratory tract and gastrointestinal tract. The agreement became effective on June 1.
News For NSPH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 3, 2015
17:06 EDTNSPHNanosphere to ask holders to approve reverse stock split
Nanosphere announced that it will conduct a special meeting of stockholders on Tuesday, April 7. At the special meeting, stockholders will be asked to approve amendments to Nanosphere's charter to increase the authorized shares of its common stock from 150M to 250M shares, and to effect a reverse stock split of its issued and outstanding common stock with a ratio in a range of between 15-to-1 and 25-to-1 for the purpose of regaining compliance with the $1 minimum bid price requirement of the NASDAQ Capital Market. The board of directors will determine the exact ratio of the reverse stock split within such range, assuming stockholders approve the reverse stock split at the special meeting. In connection with the special meeting of stockholders, Nanosphere has filed with the SEC a definitive proxy statement describing the charter amendments that will be mailed to stockholders on or about Friday, March 6 to solicit proxies in support of the charter amendments. Nanosphere has engaged MacKenzie Partners to serve as its proxy solicitor for the special meeting of stockholder.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use